Abstract
This work aims to prepare sustained release buccal mucoadhesive lyophilized chitosan sponges of buspirone hydrochloride (BH) to improve its systemic bioavailability. Chitosan sponges were prepared using simple casting/freeze-drying technique according to 32 factorial design where chitosan grade was set at three levels (low, medium, and high molecular weight), and concentration of chitosan solution at three levels (0.5, 1, and 2%). Mucoadhesion force, ex vivo mucoadhesion time, percent BH released after 8 h (Q8h), and time for release of 50% BH (T50%) were chosen as dependent variables. Additional BH cup and core buccal chitosan sponge were prepared to achieve uni-directional BH release toward the buccal mucosa. Sponges were evaluated in terms of drug content, surface pH, scanning electron microscopy, swelling index, mucoadhesion strength, ex vivo mucoadhesion time, and in vitro drug release. Cup and core sponge (HCH 0.5E) were able to adhere to the buccal mucosa for 8 h. It showed Q8h of 68.89% and exhibited a uni-directional drug release profile following Higuchi diffusion model.
Similar content being viewed by others
References
Pedro AS, Albuquerque EC, Ferreira D, Sarmento B. Chitosan: an option for development of essential oil delivery systems for oral cavity care? Carbohydr Polym. 2009;76:501–8.
Dasha M, Chiellini F, Ottenbriteb RM, Chiellini E. Chitosan—a versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci. 2011;36:981–1014.
Bernkop-Schnurch A, Dunnhaupt S. Chitosan-based drug delivery systems. Eur J Pharm Biopharm. 2012;81(3):463–9.
Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J Control Release. 2011;153(2):106–16.
Oungbho K, Müller BW. Chitosan sponges as sustained release drug carriers. Int J Pharm. 1997;156:229–37.
Lai HL, Abu'Khalil A, Craig DQ. The preparation and characterisation of drug-loaded alginate and chitosan sponges. Int J Pharm. 2003;251(1–2):175–81.
Ayensu I, Mitchell JC, Boateng JS. Development and physico-mechanical characterisation of lyophilised chitosan wafers as potential protein drug delivery systems via the buccal mucosa. Colloids Surf B: Biointerfaces. 2012;91:258–65.
Boateng JS, Auffret AD, Matthews KH, Humphrey MJ, Stevens HN, Eccleston GM. Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces. Int J Pharm. 2010;389(1–2):24–31.
Shen EC, Wang C, Fu E, Chiang CY, Chen TT, Nieh S. Tetracycline release from tripolyphosphate-chitosan cross-linked sponge: a preliminary in vitro study. J Periodontal Res. 2008;43(6):642–8.
Madhav NV, Shakya AK, Shakya P, Singh K. Orotransmucosal drug delivery systems: a review. J Control Release. 2009;140(1):2–11.
Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs. J Control Release. 2006;114(1):15–40.
Shumilov M, Touitou E. Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies. Int J Pharm. 2010;387(1–2):26–33.
Nash JR, Nutt DJ. Pharmacotherapy of anxiety. In: Holsboer F, Ströhle A, editors. Anxiety and anxiolytic drugs. Germany: Springer; 2005. p. 469–501.
Gannu R, Yamsani SK, Palem CR, Yamsani VV, Kotagiri H, Yamsani MR. Development of high performance liquid chromatography method for buspirone in rabbit serum: application to pharmacokinetic study. Anal Chim Acta. 2009;647(2):226–30.
Moffat AC, Osselton MD, Widdop B. Monographs: buspirone. In: Watts J, editor. Clarke’s analysis of drugs and poisons. 4th ed. London: Pharmaceutical Press; 2011. p. 1014–5.
Sakr A, Andheria M. Pharmacokinetics of buspirone extended-release tablets: a single-dose study. J Clin Pharmacol. 2001;41(7):783–9.
Kassem MA, Elmeshad AN, Fares AR. Enhanced bioavailability of buspirone hydrochloride via cup and core buccal tablets: formulation and in vitro/in vivo evaluation. Int J Pharm. 2014;463(1):68–80.
Foda NH, El-laithy HM, Tadros MI. Implantable biodegradable sponges: effect of interpolymer complex formation of chitosan with gelatin on the release behavior of tramadol hydrochloride. Drug Dev Ind Pharm. 2007;33(1):7–17.
Darwish MK, Elmeshad AN. Buccal mucoadhesive tablets of flurbiprofen: characterization and optimization. Drug Discov Ther. 2009;3(4):181–9.
Patel VM, Prajapati BG, Patel MM. Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS PharmSciTech. 2007;8(1):E147–54.
Morsi NM, Abdelbary GA, Ahmed MA. Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. Eur J Pharm Biopharm. 2013.
Perioli L, Ambrogi V, Giovagnoli S, Ricci M, Blasi P, Rossi C. Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen. AAPS PharmSciTech. 2007;8(3):E54.
Perioli L, Ambrogi V, Pagano C, Scuota S, Rossi C. FG90 chitosan as a new polymer for metronidazole mucoadhesive tablets for vaginal administration. Int J Pharm. 2009;377(1–2):120–7.
Al-Zoubi N, Alkhatib HS, Bustanji Y, Aiedeh K, Malamataris S. Sustained-release of buspirone HCl by co spray-drying with aqueous polymeric dispersions. Eur J Pharm Biopharm. 2008;69(2):735–42.
Joshi GV, Kevadiya BD, Bajaj HC. Design and evaluation of controlled drug delivery system of buspirone using inorganic layered clay mineral. Microporous Mesoporous Mater. 2010;132:526–30.
Foda NH, El-laithy HM, Tadros MI. Optimization of biodegradable sponges as controlled release drug matrices. I. Effect of moisture level on chitosan sponge mechanical properties. Drug Dev Ind Pharm. 2004;30(4):369–79.
Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145–9.
Peppas NA, Sahlin JJ. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm. 1989;57:169–72.
Korsmeyer R, Gumy R, Doelker E, Buri P, Peppas N. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.
Harland RS, Gazzaniga A, Sangalli ME, Colombo P, Peppas NA. Drug/polymer matrix swelling and dissolution. Pharm Res. 1988;5(8):488–94.
Ritger PL, Peppas NA. A simple equation for description of solute release II. fickian and anomalous release from swellable devices. J Control Release. 1987;5:37–42.
Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm. 1992;78:43–8.
Park H, Amiji M, Park K. Mucoadhesive hydrogels effective at neutral pH. Proc Int Symp Control Rel Bioact Mater. 1989;16:217–8.
Abruzzo A, Bigucci F, Cerchiara T, Cruciani F, Vitali B, Luppi B. Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride. Carbohydr Polym. 2011;87:581–8.
Agnihotri SA, Aminabhavi TM. Controlled release of clozapine through chitosan microparticles prepared by a novel method. J Control Release. 2004;96(2):245–59.
Polk A, Amsden B, De Yao K, Peng T, Goosen MF. Controlled release of albumin from chitosan-alginate microcapsules. J Pharm Sci. 1994;83(2):178–85.
Ko JA, Park HJ, Hwang SJ, Park JB, Lee JS. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm. 2002;249(1–2):165–74.
Genta I, Perugini P, Pavanetto F. Different molecular weight chitosan microspheres: influence on drug loading and drug release. Drug Dev Ind Pharm. 1998;24(8):779–84.
Varshosaz J, Karimzadeh S. Development of crosslinked chitosan films for oral mucosal delivery of lidocaine. Res Pharm Sci. 2007;2:43–52.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kassem, M.A.A., ElMeshad, A.N. & Fares, A.R. Lyophilized Sustained Release Mucoadhesive Chitosan Sponges for Buccal Buspirone Hydrochloride Delivery: Formulation and In Vitro Evaluation. AAPS PharmSciTech 16, 537–547 (2015). https://doi.org/10.1208/s12249-014-0243-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-014-0243-3